Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

Ashley A. Vo, Alice Peng, Mieko Toyoda, Joseph Kahwaji, Kai Cao, Chih Hung Lai, Nancy L. Reinsmoen, Rafael Villicana, Stanley C. Jordan

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1095-1102
Number of pages8
JournalTransplantation
Volume89
Issue number9
DOIs
StatePublished - May 15 2010
Externally publishedYes

ASJC Scopus Subject Areas

  • Transplantation

Keywords

  • Acute antibody-mediated rejection
  • Acute cell- mediated rejection
  • Alemtuzumab
  • Antithymocyte globulin
  • Daclizumab
  • Highly sensitized
  • IVIG
  • Kidney transplant
  • Rituximab
  • Virus Diseases/drug therapy
  • Ganciclovir/analogs & derivatives
  • Humans
  • Middle Aged
  • Antibodies, Monoclonal/therapeutic use
  • Male
  • Immunoglobulins, Intravenous/therapeutic use
  • Flow Cytometry
  • Kidney Transplantation/immunology
  • Aged, 80 and over
  • Adult
  • Female
  • Drug Therapy, Combination
  • Kidney Failure, Chronic/immunology
  • Autoantibodies/drug effects
  • Graft Rejection/prevention & control
  • Antibodies, Monoclonal, Murine-Derived
  • Valganciclovir
  • T-Lymphocytes/immunology
  • Histocompatibility Testing
  • Graft Survival
  • Survival Rate
  • Desensitization, Immunologic/methods
  • Antiviral Agents/therapeutic use
  • Adolescent
  • Aged
  • HLA Antigens/immunology
  • Immunologic Factors/therapeutic use

Cite this